Stock Events

Sensus Healthcare 

€6.1
35
-€0.25-3.94% Today

Statistics

Day High
6.1
Day Low
6.1
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
102M
P/E Ratio
16.32
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
-0.12
0.01
0.13
0.26
Expected EPS
-0.01
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5TX.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
DENTSPLY Sirona
XRAY
Mkt Cap5.13B
Dentsply Sirona offers technologies and equipment for dental and oral health, overlapping with Sensus Healthcare's dermatological treatments.
Intuitive Surgical
ISRG
Mkt Cap175.06B
Intuitive Surgical provides robotic surgical systems, competing in the broader medical device market for minimally invasive procedures, similar to Sensus' non-surgical skin treatments.
Medtronic
MDT
Mkt Cap113.61B
Medtronic offers a wide range of medical devices that compete in the healthcare solutions sector, including skin health and surgical products.
Boston Scientific
BSX
Mkt Cap120.45B
Boston Scientific Corporation produces medical devices that are used in various surgical procedures, competing with Sensus' treatment options.
Stryker
SYK
Mkt Cap137.35B
Stryker Corporation manufactures medical devices and equipment, including surgical and skin health products, competing with Sensus Healthcare.
Zimmer Biomet
ZBH
Mkt Cap23.51B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its range of surgical solutions and medical devices places it in competition with Sensus.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson offers a broad array of healthcare products, including skin health solutions that compete with Sensus Healthcare's offerings.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie Inc. engages in the development of pharmaceuticals that include dermatology treatments, competing with Sensus Healthcare's dermatological solutions.
Baxter International
BAX
Mkt Cap19.36B
Baxter International Inc. provides a portfolio of hospital and surgical products, indirectly competing with Sensus Healthcare's skin treatment technologies.

About

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Show more...
CEO
Mr. Joseph C. Sardano
Employees
35
Country
US
ISIN
US81728J1097
WKN
000A2JPJ1

Listings